Search Results

You searched for : LatestBristolMyersSquibb

	Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma ... Jul 17
	Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma ... Jun 25
	Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Recommendation based on positive results from the Phase 3 CheckMate -577 trial in which Opdivo doubled disease-free survival compared to placebo in the all-... Jun 25
	Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisaiâ€™s MORAb-202 Antibody Drug Conjugate ... Jun 18
	European Medicines Agency Validates Bristol Myers Squibbâ€™s Application for Opdivo ... Jan 05
	European Medicines Agency Validates Bristol Myers Squibbâ€™s Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis If approved, Zeposia would be the first oral sphingosine-1-phosphate (S1P) receptor modulator for the treatment of ulcerative colitis.... Dec 28
	Bristol Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed Methylated Glioblastoma Multiforme ... Dec 23
	Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic for Adult Patients with Myelofibrosis If approved, Inrebic will become the first new therapy for myelofibrosis in Europe in nearly a decade.... Dec 11
	Bristol Myers Squibb Presents Analyses from Pivotal QUAZAR AML-001 Study of Onureg Results demonstrated treatment with Onureg improved overall survival, compared to placebo, in patients with AML in first remission.... Dec 08
	Bristol Myers Squibb Receives European Commission Approval for Opdivo Bristol Myers Squibb announced the approval of Opdivo for the treatment of adults with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma ... Nov 25
	Decreases in Americans' Primary Care Visits May Lead to Late Diagnoses of Potentially Serious Conditions The Bristol Myers Squibbâ€“Pfizer Alliance, with the support of leading advocacy organizations and medical societies, announces the launch of the No Time to Wait ... Oct 26
	USFDA Accepts for Priority Review Applications for OPDIVO in Combination with CABOMETYX in Advanced Renal Cell Carcinoma Results from CheckMate -9ER recently presented during a Presidential Symposium at the European Society for Medical Oncology Virtual Congress... Oct 19
12 Matching result(s) found!

-Advertisements-

Trending Now
	Moscow Outpatient Departments to Implement AI X-ray InterpretationMay 31, 2024
	FLO launched Digital Ready Reckoner - of MSME schemes.May 31, 2024
	Candy flavoured traps to hook the next generationMay 31, 2024
	Software Engineering Research Centre (SERC) at IIIT H to host 21st Edition of IEEE International Conference on Software Architecture (ICSA) 2024May 31, 2024
	Federal Bank and Tata AIA Life Insurance Announce Strategic Bancassurance PartnershipMay 31, 2024
	Why Whole Spices are Better than Powdered: New ICMR GuidelinesMay 31, 2024
	Raising Awareness on Menstrual Health: NCW and SheWings Initiative on Menstrual Hygiene DayMay 31, 2024
	Innovative RNA Drugs Offer Hope for Patients with High CholesterolMay 31, 2024
	Advani Hotels & Resorts (India) Limited (Caravela Beach Resort, Goa)May 30, 2024
	FLO Hyderabad launches ‘Centre of Excellence for Training Women Vegetable Farming’May 30, 2024
	Should Doctors Be Exempt from the Consumer Protection Act? A Complex DebateMay 30, 2024
	Tamil Nadu Doctors Save 14-Year-Old Girl by Removing Needle from Lung with BronchoscopyMay 30, 2024
	The Lifesaving Journey of a Florist: Rare 'Bombay' Blood Group Donation Saves Life May 30, 2024
	The Impact of Heat on Eye Health: Preventing Eye Strokes During High TemperaturesMay 30, 2024
	Patients with super morbid obesity can find life-changing benefits beyond weight reduction through bariatric surgeryMay 29, 2024
	AI software could revolutionise voice box cancer treatmentMay 29, 2024
	Why You’re Waking Up to Pee: The Link Between Enlarged Prostate and NocturiaMay 29, 2024
	Rising Smoking Rates Among Teenage Girls: A Growing Health Crisis in IndiaMay 29, 2024
	WHO Launches $7 Billion Investment Round at the 77th World Health AssemblyMay 29, 2024
	From Insulin-Dependent to Insulin-Free in just 3 months: Game-Changing Diabetes Cure Developed by Chinese ScientistsMay 29, 2024

Search Results

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma

Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy

Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisaiâ€™s MORAb-202 Antibody Drug Conjugate

European Medicines Agency Validates Bristol Myers Squibbâ€™s Application for Opdivo

European Medicines Agency Validates Bristol Myers Squibbâ€™s Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis

Bristol Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed Methylated Glioblastoma Multiforme

Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic for Adult Patients with Myelofibrosis

Bristol Myers Squibb Presents Analyses from Pivotal QUAZAR AML-001 Study of Onureg

Bristol Myers Squibb Receives European Commission Approval for Opdivo

Decreases in Americans' Primary Care Visits May Lead to Late Diagnoses of Potentially Serious Conditions

USFDA Accepts for Priority Review Applications for OPDIVO in Combination with CABOMETYX in Advanced Renal Cell Carcinoma

Trending Now